Christine Brezden-Masley, MD, PhD, FRCPC
Medical Oncologist, St. Michael’s Hospital
Associate Professor, University of Toronto
Co-Director, Hematology Oncology Clinical Research Group
Associate Scientist, Li Ka Shing Knowledge Institute
President, Canadian Cardio-Oncology Network
Founder, COMET Clinical Trials Consortium
Christine Brezden-Masley, MD PhD FRCPC, is a practicing Medical Oncologist and the Division Head of Hematology/Oncology at St. Michael’s Hospital in Toronto, Canada. She is the Co-Director of the Hematology/Oncology Clinical Research Group at the same institute. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Associate Professor at the University of Toronto and an Associate Scientist at the Li Ka Shing Knowledge Institute, Toronto, Canada.
Dr Brezden-Masley is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto region. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and she has been the Co-Chair of the Annual Canadian Cardio-Oncology Network meeting, a collaborative national meeting improving cardiac heath in patients with cancer and is currently the President of the Canadian Cardio-Oncology Network. She is also on the Board of Directors of ReThink Breast Cancer, a national advocacy and support network for young women with breast cancer. She is active in research, education and has been instrumental in the clinical development of the cancer program at St. Michael’s Hospital.